NCT07038369
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07038369
Title A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Atavistik Bio, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Florida Cancer Specialists & Research Institute - Lake Mary Lake Mary Florida 32746 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Washington University St Louis Missouri 63110 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Centre Leon Berard Lyon 69008 France Details
National Cancer Centre Singapore Singapore 168583 Singapore Details
START Madrid - CIOCC Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field